1. An update on the current pharmacotherapy for endometrial cancer. (3rd March 2016) Authors: de Haydu, Christopher; Black, Jonathan D.; Schwab, Carlton L.; English, Diana P.; Santin, Alessandro D. Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 4(2016) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clostridium perfringens enterotoxin C‐terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy‐resistant ovarian cancer. Issue 11 (18th August 2015) Authors: Cocco, Emiliano; Shapiro, Erik M.; Gasparrini, Sara; Lopez, Salvatore; Schwab, Carlton L.; Bellone, Stefania; Bortolomai, Ileana; Sumi, Natalia J.; Bonazzoli, Elena; Nicoletti, Roberta; Deng, Yang; Saltzman, W. Mark; Zeiss, Caroline J.; Centritto, Floriana; Black, Jonathan D.; Silasi, Dan‐Arin; R... Journal: International journal of cancer Issue: Volume 137:Issue 11(2015:Dec. 01) Page Start: 2618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers. (2nd August 2016) Authors: Menderes, Gulden; Hicks, Christopher; Black, Jonathan D.; Schwab, Carlton L.; Santin, Alessandro D. Journal: Expert opinion on biological therapy Issue: Volume 16:Number 8(2016:Aug.) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunotherapy and targeted therapy for cervical cancer: an update. Issue 1 (2nd January 2016) Authors: Menderes, Gulden; Black, Jonathan; Schwab, Carlton L.; Santin, Alessandro D. Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 1(2016) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer. (2nd July 2016) Authors: English, Diana P.; Menderes, Gulden; Black, Jonathan; Schwab, Carlton L.; Santin, Alessandro D. Journal: Expert review of molecular diagnostics Issue: Volume 16:Number 7(2016) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy‐resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. Issue 3 (23rd September 2014) Authors: English, Diana P.; Bellone, Stefania; Schwab, Carlton L.; Roque, Dana M.; Lopez, Salvatore; Bortolomai, Ileana; Cocco, Emiliano; Bonazzoli, Elena; Chatterjee, Sudeshna; Ratner, Elena; Silasi, Dan‐Arin; Azodi, Masoud; Schwartz, Peter E.; Rutherford, Thomas J.; Santin, Alessandro D. Journal: Cancer Issue: Volume 121:Issue 3(2015) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy‐resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. Issue 3 (23rd September 2014) Authors: English, Diana P.; Bellone, Stefania; Schwab, Carlton L.; Roque, Dana M.; Lopez, Salvatore; Bortolomai, Ileana; Cocco, Emiliano; Bonazzoli, Elena; Chatterjee, Sudeshna; Ratner, Elena; Silasi, Dan‐Arin; Azodi, Masoud; Schwartz, Peter E.; Rutherford, Thomas J.; Santin, Alessandro D. Journal: Cancer Issue: Volume 121:Issue 3(2015) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Role of the Immune System in Ovarian Cancer and Implications on Therapy. (2nd June 2016) Authors: Menderes, Gulden; Schwab, Carlton L.; Black, Jonathan; Santin, Alessandro D. Journal: Expert review of clinical immunology Issue: Volume 12:Number 6(2016) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. T‐DM1, a novel antibody–drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo. (2nd June 2014) Authors: English, Diana P.; Bellone, Stefania; Schwab, Carlton L.; Bortolomai, Ileana; Bonazzoli, Elena; Cocco, Emiliano; Buza, Natalia; Hui, Pei; Lopez, Salvatore; Ratner, Elena; Silasi, Dan‐Arin; Azodi, Masoud; Schwartz, Peter E.; Rutherford, Thomas J.; Santin, Alessandro D. Journal: Cancer medicine Issue: Volume 3:Number 5(2014:Oct.) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗